Anthracycline Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting anthracycline clinical trials across 11 countries. Studies span Not Applicable, Phase 2, Phase 1. Top locations include Alcalá de Henares, Spain, Amsterdam, Netherlands, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Anthracycline Trials at a Glance

8 actively recruiting trials for anthracycline are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Alcalá de Henares, Amsterdam, and Barcelona. Lead sponsors running anthracycline studies include Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, IRCCS Burlo Garofolo, and Dr James Hare.

Browse anthracycline trials by phase

Treatments under study

About Anthracycline Clinical Trials

Looking for clinical trials for Anthracycline? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anthracycline trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anthracycline clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy

CardiotoxicityAnthracycline-induced Cardiotoxicity
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)93 enrolled1 locationNCT07528586
Recruiting
Phase 2

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Breast CancerHeart FailureAnthracycline-induced Cardiac Toxicity+2 more
University Medical Centre Ljubljana100 enrolled1 locationNCT07245069
Recruiting
Not Applicable

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Anthracycline-induced Cardiac ToxicityLymphoma
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III608 enrolled24 locationsNCT05223413
Recruiting
Not Applicable

Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients

Breast NeoplasmsAlopeciaMadarosis+5 more
University of Salamanca120 enrolled2 locationsNCT06955702
Recruiting

Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients

Heart InjuriesAnthracycline
IRCCS Burlo Garofolo22 enrolled1 locationNCT06898320
Recruiting
Phase 1Phase 2

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center70 enrolled1 locationNCT03934905
Recruiting

Using cardiac magnetic resonance imaging to detect early changes in heart muscle that may help predict patients who are at risk of developing toxicity from anthracycline chemotherapy.

Anthracycline chemotherapy induced cardiac toxicityLymphoma
Dr James Hare50 enrolled1 locationACTRN12612001100886
Recruiting

Inter-ethnic differences in tolerance of anti-cancer drugs in breast cancer patients

tolerance of adjuvant anthracycline-based chemotherapy in breast cancer patients
Sydney Cancer Centre120 enrolled1 locationACTRN12610000045011